Thrombin peptide (TP508) promotes adipose tissue-derived stem cell proliferation via PI3 kinase/Akt pathway

Journal of Vascular Research

Volumn 46, Issue 2, 2009, Pages 98-102

  Freyberg, Susanne ^a   Song, Yao Hua ^a   Muehlberg, Fabian ^a   Alt, Eckhard ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Proliferating capacity; Stem cells; Wound healing

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; BROXURIDINE; PHOSPHATIDYLINOSITOL 3 KINASE; THROMBIN; TP 508; UNCLASSIFIED DRUG;

ADIPOSE TISSUE; ANGIOGENESIS; ARTICLE; CASE REPORT; CELL PROLIFERATION; CONTROLLED STUDY; DRUG BINDING; DRUG EFFICACY; DRUG MECHANISM; HUMAN; HUMAN TISSUE; PHOSPHORYLATION; PRIORITY JOURNAL; RECEPTOR BINDING; STEM CELL; THERAPY EFFECT; WESTERN BLOTTING; WOUND HEALING;

1-PHOSPHATIDYLINOSITOL 3-KINASE; BROMODEOXYURIDINE; CELL PROLIFERATION; CELLS, CULTURED; CHROMONES; HUMANS; MORPHOLINES; PEPTIDE FRAGMENTS; PHOSPHORYLATION; PROTEIN KINASE INHIBITORS; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTORS, THROMBIN; SIGNAL TRANSDUCTION; STEM CELLS; SUBCUTANEOUS FAT; THROMBIN; WOUND HEALING;

EID: 60349083978     PISSN: 10181172     EISSN: None     Source Type: Journal    
DOI: 10.1159/000142727     Document Type: Article

References (35)

1. Dery O, Corvera CU, Steinhoff M, Bunnett NW: Proteinase-activated receptors: novel mechanisms of signaling by serine proteases. Am J Physiol 1998;274:C1429-C1452.
2. Coughlin SR: Thrombin signalling and protease-activated receptors. Nature 2000;407:258-264.
3. Macfarlane SR, Seatter MJ, Kanke T, Hunter GD, Plevin R: Proteinase-activated receptors. Pharmacol Rev 2001;53:245-282.
4. Kahn ML, Zheng YW, Huang W, Bigornia V, Zeng D, Moff S, Farese RV Jr, Tam C, Coughlin SR: A dual thrombin receptor system for platelet activation. Nature 1998;394:690-694.
5. Nakanishi-Matsui M, Zheng YW, Sulciner DJ, Weiss EJ, Ludeman MJ, Coughlin SR: PAR3 is a cofactor for PAR4 activation by thrombin. Nature 2000;404:609-613.
6. O'Brien PJ, Prevost N, Molino M, Hollinger MK, Woolkalis MJ, Woulfe DS, Brass LF: Thrombin responses in human endothelial cells. Contributions from receptors other than PAR1 include the transactivation of PAR2 by thrombin-cleaved PAR1. J Biol Chem 2000;275:13502-13509.
7. Carney DH, Herbosa GJ, Stiernberg J, Bergmann JS, Gordon EA, Scott D, Fenton JW 2nd: Double-signal hypothesis for thrombin initiation of cell proliferation. Semin Thromb Hemost 1986;12:231-240.
8. Carney DH, Redin W, McCroskey L: Role of high-affinity thrombin receptors in post-clotting cellular effects of thrombin. Semin Thromb Hemost 1992;18: 91-103.
9. Glenn KC, Frost GH, Bergmann JS, Carney DH: Synthetic peptides bind to high-affinity thrombin receptors and modulate thrombin mitogenesis. Pept Res 1988;1:65-73.
10. Sower LE, Payne DA, Meyers R, Carney DH: Thrombin peptide, TP508, induces differential gene expression in fibroblasts through a nonproteolytic activation pathway. Exp Cell Res 1999;247:422-431.
11. Stiernberg J, Norfleet AM, Redin WR, Warner WS, Fritz RR, Carney DH: Acceleration of full-thickness wound healing in normal rats by the synthetic thrombin peptide, TP508. Wound Repair Regen 2000;8:204-215.
12. Carney DH, Mann R, Redin WR, Pernia SD, Berry D, Heggers JP, Hayward PG, Robson MC, Christie J, Annable C, et al: Enhancement of incisional wound healing and neovascularization in normal rats by thrombin and synthetic thrombin receptor-activating peptides. J Clin Invest 1992;89:1469-1477.
13. Cromack DT, Porras-Reyes BH, Wee SS, Glenn KC, Purdy JA, Carney DH, Mustoe TA: Acceleration of soft tissue repair by a thrombin-derived oligopeptide. J Surg Res 1992;53:117-122.
14. Norfleet AM, Huang Y, Sower LE, Redin WR, Fritz RR, Carney DH: Thrombin peptide TP508 accelerates closure of dermal excisions in animal tissue with surgically induced ischemia. Wound Repair Regen 2000;8:517-529.
15. Wang H, Li X, Tomin E, Doty SB, Lane JM, Carney DH, Ryaby JT: Thrombin peptide (TP508) promotes fracture repair by upregulating inflammatory mediators, early growth factors, and increasing angiogenesis. J Orthop Res 2005;23:671-679.
16. Sheller MR, Crowther RS, Kinney JH, Yang J, Di Jorio S, Breunig T, Carney DH, Ryaby JT: Repair of rabbit segmental defects with the thrombin peptide, TP508. J Orthop Res 2004;22:1094-1099.
17. Li G, Ryaby JT, Carney DH, Wang H: Bone formation is enhanced by thrombin-related peptide TP508 during distraction osteogenesis. J Orthop Res 2005;23:196-202.
18. Fife C, Mader JT, Stone J, Brill L, Satterfield K, Norfleet A, Zwernemann A, Ryaby JT, Carney DH: Thrombin peptide Chrysalin stimulates healing of diabetic foot ulcers in a placebo-controlled phase I/II study. Wound Repair Regen 2007;15:23-34.
19. Sadat S, Gehmert S, Song YH, Yen Y, Bai X, Gaiser S, Klein H, Alt E: The cardioprotective effect of mesenchymal stem cells is mediated by IGF-I and VEGF. Biochem Biophys Res Commun 2007;363:674-679.
20. Gimble J, Guilak F: Adipose-derived adult stem cells: isolation, characterization, and differentiation potential. Cytotherapy 2003;5:362-369.
21. Bai X, Sadat S, Gehmert S, Alt E, Song YH: VEGF receptor Flk-1 plays an important role in c-kit expression in adipose tissue derived stem cells. FEBS Lett 2007;581:4681-4684.
22. Bai X, Ma J, Pan Z, Song YH, Freyberg S, Yan Y, Vykoukal D, Alt E: Electrophysiological properties of human adipose tissue-derived stem cells. Am J Physiol Cell Physiol 2007;293:C1539-C1550.
23. Smadja DM, Bieche I, Uzan G, Bompais H, Muller L, Boisson-Vidal C, Vidaud M, Aiach M, Gaussem P: PAR-1 activation on human late endothelial progenitor cells enhances angiogenesis in vitro with upregulation of the SDF-1/CXCR4 system. Arterioscler Thromb Vasc Biol 2005;25:2321-2327.
24. Tarzami ST, Wang G, Li W, Green L, Singh JP: Thrombin and PAR-1 stimulate differentiation of bone marrow-derived endothelial progenitor cells. J Thromb Haemost 2006;4:656-663.
25. Huang YQ, Li JJ, Hu L, Lee M, Karpatkin S: Thrombin induces increased expression and secretion of VEGF from human FS4 fibroblasts, DU145 prostate cells and CHRF megakaryocytes. Thromb Haemost 2001;86:1094-1098.
26. Olivot JM, Estebanell E, Lafay M, Brohard B, Aiach M, Rendu F: Thrombomodulin prolongs thrombin-induced extracellular signal-regulated kinase phosphorylation and nuclear retention in endothelial cells. Circ Res 2001;88:681-687.
27. Kataoka H, Hamilton JR, McKemy DD, Camerer E, Zheng YW, Cheng A, Griffin C, Coughlin SR: Protease-activated receptors 1 and 4 mediate thrombin signaling in endothelial cells. Blood 2003;102:3224-3231.
28. Smadja DM, Laurendeau I, Avignon C, Vidaud M, Aiach M, Gaussem P: The angiopoietin pathway is modulated by PAR-1 activation on human endothelial progenitor cells. J Thromb Haemost 2006;4:2051-2058.
29. Hildbrand P, Cirulli V, Prinsen RC, Smith KA, Torbett BE, Salomon DR, Crisa L: The role of angiopoietins in the development of endothelial cells from cord blood CD34+ progenitors. Blood 2004;104:2010-2019.
30. Tsopanoglou NE, Papaconstantinou ME, Flordellis CS, Maragoudakis ME: On the mode of action of thrombin-induced angiogenesis: thrombin peptide, TP508, mediates effects in endothelial cells via alphavbeta3 integrin. Thromb Haemost 2004;92: 846-857.
31. Li X, Wang H, Touma E, Qi Y, Rousseau E, Quigg RJ, Ryaby JT: TP508 accelerates fracture repair by promoting cell growth over cell death. Biochem Biophys Res Commun 2007;364:187-193.
32. Naldini A, Carraro F, Baldari CT, Paccani SR, Bernini C, Keherly MJ, Carney DH: The thrombin peptide, TP508, enhances cytokine release and activates signaling events. Peptides 2004;25:1917-1926.
33. Norfleet AM, Bergmann JS, Carney DH: Thrombin peptide, TP508, stimulates angiogenic responses in animal models of dermal wound healing, in chick chorioallantoic membranes, and in cultured human aortic and microvascular endothelial cells. Gen Pharmacol 2000;35:249-254.
34. Valina C, Pinkernell K, Song YH, Bai X, Sadat S, Campeau RJ, Le Jemtel TH, Alt E: Intracoronary administration of autologous adipose tissue-derived stem cells improves left ventricular function, perfusion, and remodelling after acute myocardial infarction. Eur Heart J 2007;28:2667-2677.
35. Vojtassak J, Danisovic L, Kubes M, Bakos D, Jarabek L, Ulicna M, Blasko M: Autologous biograft and mesenchymal stem cells in treatment of the diabetic foot. Neuro Endocrinol Lett 2006;27(suppl 2):134-137.